EP1098659A4 - Banques de polyhydroxamates et leurs analogues - Google Patents

Banques de polyhydroxamates et leurs analogues

Info

Publication number
EP1098659A4
EP1098659A4 EP99937465A EP99937465A EP1098659A4 EP 1098659 A4 EP1098659 A4 EP 1098659A4 EP 99937465 A EP99937465 A EP 99937465A EP 99937465 A EP99937465 A EP 99937465A EP 1098659 A4 EP1098659 A4 EP 1098659A4
Authority
EP
European Patent Office
Prior art keywords
polyhydroxamates
libraries
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99937465A
Other languages
German (de)
English (en)
Other versions
EP1098659A2 (fr
Inventor
Garland R Marshall
Leonard O Rosik
Otto F Schall
Urszula J Slomczynska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METAPHORE Inc
Original Assignee
METAPHORE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAPHORE Inc filed Critical METAPHORE Inc
Publication of EP1098659A2 publication Critical patent/EP1098659A2/fr
Publication of EP1098659A4 publication Critical patent/EP1098659A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EP99937465A 1998-07-23 1999-07-23 Banques de polyhydroxamates et leurs analogues Withdrawn EP1098659A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9388398P 1998-07-23 1998-07-23
US93883P 1998-07-23
PCT/US1999/016848 WO2000004868A2 (fr) 1998-07-23 1999-07-23 Banques de polyhydroxamates et leurs analogues

Publications (2)

Publication Number Publication Date
EP1098659A2 EP1098659A2 (fr) 2001-05-16
EP1098659A4 true EP1098659A4 (fr) 2004-11-24

Family

ID=22241527

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99937465A Withdrawn EP1098659A4 (fr) 1998-07-23 1999-07-23 Banques de polyhydroxamates et leurs analogues

Country Status (5)

Country Link
EP (1) EP1098659A4 (fr)
JP (1) JP2002521319A (fr)
AU (1) AU5229599A (fr)
CA (1) CA2337756A1 (fr)
WO (1) WO2000004868A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1155019B1 (fr) 1999-01-25 2005-12-07 National Jewish Medical and Research Center Porphyrines substituees et leur utilisation therapeutique
US20030032634A1 (en) 2001-06-01 2003-02-13 Piganelli Jon D. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
CA2426731A1 (fr) * 2000-10-23 2002-06-20 Genetics Institute, Llc. Agent d'extraction a code isotopique instable vis-a-vis de l'acide et son utilisation dans l'analyse spectrometrique de masse quantitative de melanges de proteines
MXPA03011387A (es) * 2001-06-08 2005-03-07 Metaphore Pharmaceuticals Inc Genotecas de peptidos azacoronas quirales y peptidomimeticos conformacionalmente restringidos y metodos parahacer los mismos.
EP2732817B1 (fr) 2008-05-23 2016-08-24 National Jewish Health Composé destiné à être utilisé dans le traitement d'une lésion associée à l'exposition à du phosgène ou du chlore gazeux
US9334716B2 (en) 2012-04-12 2016-05-10 Halliburton Energy Services, Inc. Treatment fluids comprising a hydroxypyridinecarboxylic acid and methods for use thereof
WO2015140212A1 (fr) * 2014-03-19 2015-09-24 Universität Zürich Agents bifonctionnels multidentates de chélation pour la complexation de radionucléides en diagnostic et en thérapie
WO2019197469A1 (fr) * 2018-04-10 2019-10-17 Sanofi-Aventis Deutschland Gmbh Synthèse de lixisénatide comprenant une étape de coiffage
CN110270133A (zh) * 2019-07-30 2019-09-24 深圳市百迈生命科学有限公司 一种基于pe筛板偶联化学基团的整体柱板制备方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322961A (en) * 1992-12-09 1994-06-21 University Of Florida Analogs of desferrioxamine B and method for synthesis thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987253A (en) * 1988-09-19 1991-01-22 University Of Florida Method for the synthesis of desferrioxamine B and analogs thereof
GB9503749D0 (en) * 1995-02-24 1995-04-12 British Biotech Pharm Synthesis of hydroxamic acid derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322961A (en) * 1992-12-09 1994-06-21 University Of Florida Analogs of desferrioxamine B and method for synthesis thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MILLER S C ET AL: "SITE-SELECTIVE N-METHYLATION OF PEPTIDES ON SOLID SUPPORT", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 119, 1997, pages 2301 - 2302, XP001128157, ISSN: 0002-7863 *
See also references of WO0004868A3 *

Also Published As

Publication number Publication date
EP1098659A2 (fr) 2001-05-16
CA2337756A1 (fr) 2000-02-03
AU5229599A (en) 2000-02-14
JP2002521319A (ja) 2002-07-16
WO2000004868A3 (fr) 2000-05-04
WO2000004868A2 (fr) 2000-02-03

Similar Documents

Publication Publication Date Title
PL339551A1 (en) Derivatives of rezorcin
IL137616A0 (en) Variants of vegf-a
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EP1033994A4 (fr) Methodes de preparation de bioginko
EP1076565A4 (fr) Analogues d'indolicidine et leurs procedes d'utilisation
SG67408A1 (en) Synthesis of analogs of pth and pthrp
EP1045689A4 (fr) Synthese de phenstatine et promedicaments de celle-ci
EP1021407A4 (fr) Synthese de clasto-lactacystine beta-lactone et de ses analogues
EP1098659A4 (fr) Banques de polyhydroxamates et leurs analogues
GB9602704D0 (en) Structure of perculator
PL334769A1 (en) Derivatives of 5-aroylnaphtene
IL138647A0 (en) Synthesis of compounds and libraries of compounds
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
ZA985064B (en) Derivatives of pentaerythrits
EP1135023A4 (fr) Composes aminobenzisoxazole et banques contenant de tels composes
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
IL130670A0 (en) Manufacture of elongate members
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
TW319017U (en) Improved structure of mousetraps
TW312301U (en) Improved structure of earmask
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
PL327430A1 (en) Set of shaped components
TW312131U (en) Improved structure of earflaps
TW317745U (en) Improved structure of mini-duster
TW323471U (en) Improved structure of hairclip

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010213

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SLOMCZYNSKA, URSZULA, J.

Inventor name: SCHALL, OTTO, F.

Inventor name: ROSIK, LEONARD, O.

Inventor name: MARSHALL, GARLAND, R.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07C 259/06 B

Ipc: 7C 07C 259/04 B

Ipc: 7C 07C 255/00 B

Ipc: 7C 07C 241/00 B

Ipc: 7C 07C 239/00 B

Ipc: 7C 07C 233/00 B

Ipc: 7C 07K 5/00 B

Ipc: 7G 01N 33/543 B

Ipc: 7G 01N 33/566 B

Ipc: 7G 01N 33/567 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61K 38/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20041011

17Q First examination report despatched

Effective date: 20050513

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050924

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1038178

Country of ref document: HK